Skip to main content

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Mark Dreher, Ph.D. – who was Vice President of Science and Regulatory Affairs of POM Wonderful LLC from approximately August 2005 to May 2009 – made false and unsubstantiated claims that POM Wonderful 100% Pomegranate Juice and POMx supplements prevent or treat heart disease and prostate cancer.

The FTC Order bars Dreher from making any disease treatment or prevention claim in advertising for a POM Wonderful product unless the claim is not misleading and comports with FDA requirements.  The Order further prohibits Dreher from making other health claims for a food, drug, or dietary supplement for human use, including as an expert endorser, without competent and reliable scientific evidence to support the claim.  The Order also contains a cooperation clause, and reporting provisions to help the FTC monitor compliance.  The FTC’s case against POM Wonderful LLC and others is ongoing.

The Commission vote approving the final order was 5-0. (FTC File No. 0823122; the staff contact is Janet Evans, Bureau of Consumer Protection, 202-326-2125; see press release, complaint, and consent order dated September 27, 2010.)

Copies of the documents mentioned in this release are available from the FTC’s website at and from the FTC’s Consumer Response Center, Room 130, 600 Pennsylvania Avenue, N.W., Washington, DC 20580.  Call toll-free: 1-877-FTC-HELP.

Contact Information

Office of Public Affairs